Simple
I've posted these before so I do apologize if its repetitive. Vanc has no sales strategy, has no unique products or offerings, has no corporate account listings, has too much product in the market with short dating. the only reason there are sales in Alberta with Pioglitazone is that they lowered their price to match Accel pharma's price. Since they then become the lowest, there was only two choices. So some pharmacy groups don't like Accel since they do not pay any PA's. So I don't know why people are worried about the current board vs Aziz as none of them want create a company based on net sales and pipeline contracts, they just want to play the PP game with finders fees. So bashing one guy vs the other dosnt make sense, unless your doing it to all board members.